12/27/23 18:30 | 12/26/23 | CGEM | Cullinan Oncology, Inc. | | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | S | -39 | 9.24 | 0 | -4 | -4 | 112 | D | | | | | | | | | | | | | | |
6/29/23 16:59 | 6/28/23 | CGEM | Cullinan Oncology, Inc. | | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | S | -9 | 11.40 | 0 | -1 | -1 | 116 | D | | | | | | | | | | | | | | |
5/24/23 16:36 | 5/23/23 | CGEM | Cullinan Oncology, Inc. | | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | S | -6 | 9.15 | 0 | -1 | -1 | 117 | D | | | | | | | | | | | | | | |
4/26/23 16:23 | 4/25/23 | CGEM | Cullinan Oncology, Inc. | | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | S | -8 | 10.59 | 0 | -1 | -1 | 117 | D | | | | | | | | | | | | | | |
3/27/23 16:05 | 3/23/23 | CGEM | Cullinan Oncology, Inc. | | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | S | -7 | 10.51 | 0 | -1 | -1 | 118 | D | | | | | | | | | | | | | | |
6/7/22 16:33 | 6/6/22 | CGEM | Cullinan Oncology, Inc. | | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | P | 100 | 12.40 | 0 | 8 | New | 8 | D | | | | | | | | | | | | | | |
1/5/21 20:13 | 12/31/20 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Ahmed Nadim | NY | O | EVP,P,He | M.d | 0 | 0.00 | 0 | 15 | 58 | 41 | D | | | | | | | | | | | | | | |
12/3/20 20:24 | 12/2/20 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Ahmed Nadim | NY | O | EVP,P,He | M.d | 0 | 0.00 | 0 | 7 | 24 | 34 | D | | | | | | | | | | | | | | |
11/3/20 16:28 | 10/30/20 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Ahmed Nadim | NY | O | EVP,P,He | M.d | 0 | 0.00 | 0 | 5 | 18 | 30 | D | | | | | | | | | | | | | | |
5/5/20 16:49 | 5/1/20 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Ahmed Nadim | NY | O | EVP,P,He | M.d | 0 | 0.00 | 0 | 3 | 12 | 28 | D | | | | | | | | | | | | | | |
3/3/20 20:04 | 3/1/20 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Ahmed Nadim | NY | O | P,Hemato | M.d | 0 | 0.00 | 0 | 17 | 185 | 27 | D | | | | | | | | | | | | | | |
2/6/20 20:48 | 2/4/20 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Ahmed Nadim | NY | O | P,Hemato | M.d | 0 | 0.00 | 0 | 2 | 13 | 18 | D | | | | | | | | | | | | | | |
11/4/19 16:05 | 10/31/19 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Ahmed Nadim | NJ | O | P,GLOBAL | M.d | 0 | 0.00 | 0 | 3 | 24 | 17 | D | | | | | | | | | | | | | | |
5/6/19 16:05 | 5/2/19 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Ahmed Nadim | NJ | O | P,HEMATO | M.d | 0 | 0.00 | 0 | 2 | 12 | 15 | D | | | | | | | | | | | | | | |
12/18/18 18:26 | 12/16/18 | CELG | Celgene Corp /de/ | DE | Health | Drug | Pharmaceutical Preparations | Ahmed Nadim | NJ | O | P,HEMATO | M.d | 0 | 0.00 | 0 | 3 | 29 | 13 | D | | | | | | | | | | | | | | |